RBC Bioscience

RBC Bioscience PP&E per Employee

PP&E per Employee of RBC Bioscience (6848.TWO) as of Oct 19, 2026.

PP&E per Employee

-TWD

Last updated:

PP&E per Employee of RBC Bioscience is 2026 - TWD. PP&E per Employee of RBC Bioscience was 2025 - TWD. It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

RBC Bioscience Stock analysis

What does RBC Bioscience do? RBC Bioscience Corp, based in Taipei, Taiwan, operates in the Health Care sector within the Life Sciences Tools & Services industry. The company manufactures reagents and devices for life science and molecular diagnosis, including instruments with ultraviolet sterilization systems and disposable reagent strips for nucleic acid extraction. Its products, featuring cellulose-embedded magnetic beads, purify DNA and RNA from various sources for diagnostic and forensic applications. Listed on 25 October 2021, RBC Bioscience serves markets requiring advanced molecular analysis tools. RBC Bioscience is one of the most popular companies on Eulerpool.

Frequently Asked Questions about RBC Bioscience stock

On Eulerpool you can find the complete historical development of PP&E per Employee RBC Bioscience since 2006 – with annual values, charts, and detailed analysis.

PP&E per employee measures the physical capital intensity per worker. Higher values indicate more capital-intensive operations.

PP&E per Employee's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track PP&E per Employee's RBC Bioscience historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Workforce — RBC Bioscience

All Key Metrics — RBC Bioscience